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Abstract: Total laryngectomy, a surgical treatment for extensive cancer of larynx, which
alters swallowing and respiration in patients, is followed up with a surgical voice restoration
procedure comprising tracheoesophageal puncture techniques with insertion of a ‘‘voice
prosthesis’’ to improve successful voice rehabilitation. However, microbial colonization is a
major drawback of these devices. Antimicrobials are usually used to prevent the colonization
of silicone rubber voice prostheses by microorganisms. However, long-term medication
induces the development of resistant strains with all associated risks and the development of
alternative prophylactic and therapeutic agents, including probiotics and biosurfactants, have
been suggested. The inhibition of microbial growth on surfaces can also be achieved by several
other techniques involving the modification of physicochemical properties of the biomaterial
surface or the covalently binding of antimicrobial agents to the biomaterial surface. An
overview of the different approaches investigated to date and future perspectives to reduce the
frequent replacements of voice prostheses in laryngectomized patients through microbial
biofilm retardation is presented and discussed. ' 2006 Wiley Periodicals, Inc. J Biomed Mater Res
Part B: Appl Biomater 81B: 358–370, 2007
Keywords: voice prosthesis; biofilm; prophylactic treatment; surface modifications; bio-
surfactants
INTRODUCTION
Different methods of rehabilitating the lost voice of laryngec-
tomized patients have been developed as the inability to speak
is the most disabling consequence of total laryngectomy. The
main procedure for speech rehabilitation of patients is the
insertion of silicone rubber voice prosthesis in a surgically
created tracheoesophageal ﬁstula. Since the introduction of
the ﬁrst reliable voice prosthesis by Singer and Blom in 1980,
the success rate of vocal rehabilitation after total laryngec-
tomy has improved considerably.1,2 There are different types
of voice prostheses: nonindwelling (removable) devices,
which have to be removed regularly for cleaning purposes,
such as the Blom and Singer1 and Panje,3 and the indwelling
devices, which remain in the stand for a longer period of
time, such as the Groningen button,4 Traissac et al.,5 Nijdam
et al.,6 Provox17 and Stafﬁeri and Stafﬁeri.8 Indwelling voice
prostheses are generally preferred by laryngectomees, as many
patients are inept due to lack of manual dexterity or reluc-
tance to handle the prosthesis. Therefore, nonindwelling voice
prostheses are especially allocated to motivated patients will-
ing to be autonomous. Moreover, in the United States, for
example where health service is expensive and patients have
to overcome large distances to reach a laryngologist, non-
indwelling voice prostheses are more frequently used than in
Western Europe.
The self-retaining low resistance Provox voice prosthesis,
developed in the Netherlands Cancer Institute in 19889 to-
gether with the Groningen button voice prosthesis are the
most commonly used devices in Europe at present. Table I
summarizes a comparison of the features, advantages, and
disadvantages for the most common Dutch voice prostheses.
All indwelling silicone rubber voice prostheses suffer
from microbial bioﬁlm formation along the time, leading to
dysfunction and, eventually, replacement. Therefore, micro-
bial colonization and bioﬁlm formation have been reported
to lead to salivary leakage through the prosthesis valve, sal-
ivary leakage around the prosthesis, deterioration of the
prosthesis, and increased airﬂow resistance due to valve
mechanism blocking.10,12
The aim of this paper is to review the current know-
ledge on such bioﬁlm formation and the different appro-
aches developed so far to inhibit or minimize its formation
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through interference with microbial adhesion, growth, or
survival.
BIOFILM FORMATION ON VOICE PROSTHESES
Several strategies seem useful to prevent bioﬁlm formation
on voice prostheses. In general, the main goal is to modify
the physicochemical properties of the surface in order to
reduce the force of attraction between microorganisms and
the surface of the biomaterial. For example, bacterial adhe-
sion on highly negatively charged biomaterials is low.15
Keogh and Eaton16 have shown that albumin and heparin
coatings decrease the adhesiveness of biomaterials. How-
ever, microorganisms always seem to be able to adhere to
some extent to solid materials. Moreover, when proteins
are present they can cover an antiadhesive biomaterial and
become the anchors for the adhesion of microorganisms.
Another approach to prevent bioﬁlm formation is to in-
hibit the growth of the adhering microorganisms. This can
be achieved through the design of antibiotic releasing bio-
materials. A disadvantage of such an application is that it
only works for a few days to weeks, as the amount of anti-
biotic that is actually released is limited and does not
exceed 15% of the total amount incorporated.17 Moreover,
there is a serious problem with antibiotic releasing materi-
als, namely related to the low dose actually released, which
leads to the development of antibiotic resistant microbial
strains.18 Also, the use of new techniques for covalently
binding an active antimicrobial agent onto the biomaterial
surface has been reported as alternative. For example, poly-
mers with incorporated quaternary ammonium groups have
shown such antimicrobial activity in vitro.19–21
Characteristics of Bioﬁlms on Silicone Rubber
Voice Prostheses
Microorganisms can colonize on surfaces of biomedical
devices in vivo, resulting in damage of the devices and
sometimes in infection. Voice prostheses are nonimplanted
devices in contact with the open air, thus in a nonsterile
environment and consequently prone to microbial coloniza-
tion. Voice prostheses are mainly made of medical grade
silicone rubber because of its excellent mechanical and
moulding properties. Although silicone rubber has long
been considered as an inert biomaterial, this notion has
been questioned22 because of the problems arising with sili-
cone-ﬁlled breast implants. Since then, it has been estab-
lished that silicone rubber devices have the tendency to
become quickly colonized by microorganisms,23,24 most
notably Candida species,25–29 resulting for example in fre-
quent replacement of indwelling voice prostheses.10,27,30
Neu et al.24 studied the biodeterioration of medical-
grade silicone used for voice prostheses. The yeasts in the
mixed bioﬁlm formed on the prostheses were found to be
directly responsible for the material defects. The same
authors27 also investigated the taxonomy of the microﬂora
on explanted silicone rubber voice prostheses and reported
that most of the bacteria were mainly streptococci and the
yeasts were mainly Candida species.
Van der Mei et al.31 carried out an electron microscopy
investigation for the ingrowth features as seen in vivo for
Candida strains using a modiﬁed Robbins device. The
onset of the ingrowth features observed in vivo were shown
by all strains: sometimes in the form of a small group of
yeasts growing into a hole-like defect or, at other times, in
the form of clearly visible imprints on the silicone rubber,
left after detachment of adhering yeasts during preparation
of the samples for electron microscopy. Although Candida
species are believed to be responsible for microbial over-
growth on the voice prostheses, the role of bacteria has also
been emphasized.30,32–35
Ell et al.32 studied the microﬂora of 55 failed Groningen
buttons. In those where valve failure occurred due to leak-
age (n ¼ 25), there was a positive correlation between bio-
fouling in the lumen of the valve and the number of
streptococci cultured. In valves failing due to increased air
ﬂow resistance, enterococci were particularly found on the
esophageal side of the voice prostheses. In another study,
Van Weissenbruch et al.30 identiﬁed 14 different yeast spe-
cies in association with other commensals of the oral ﬂora.
The yeast strains were the most distinctive colonizers of
the prostheses representing 72.9% of the total number of
microorganisms, among which Candida albicans and Can-
dida glabrata were predominant. Staphylococcus aureus
was also found to be another predominant microorganism
in all cultures and it was often isolated in association with
Candida strains.30,34 Others, such as Rothia dentocariosa,
have been suggested as causative organisms for prosthesis
failure by Elving et al.36,37 Only R. dentocariosa and
S. aureus appear to positively inﬂuence adhesion to silicone
rubber of yeast species from saliva, especially of C. albi-
cans.35 Interestingly, this observation coincides with clini-
cal ﬁndings that the malfunctioning of silicone rubber
voice prostheses occurs more rapidly when either R. dento-
cariosa or S. aureus are present in the bioﬁlm in combina-
tion with C. albicans, a form of positive synergistic
interactive relationship.
MODIFICATIONS OF SILICONE
RUBBER SURFACES
Voice prostheses are continuously exposed to saliva, food,
and drinks that together with the oropharyngeal microﬂora
contribute to valve failure and frequent exchange of the
implant.25 Therefore, the antifouling improvement of the
silicone rubber material is desirable. In case of laryngec-
tomized patients with voice prostheses (average lifetimes
less than two months) it is necessary to employ ‘‘anti-
bioﬁlm’’ therapy from the time of insertion of the prosthe-
ses, preferably without using antimycotics or antibiotics
due to the risk of inducing resistant strains.38,39 Different
approaches have been undertaken to modify the silicone
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rubber surface as an obvious strategy to inhibit bioﬁlm for-
mation and consequently to prolong the lifetime of voice
prostheses. Although voice prostheses will become covered
by a conditioning ﬁlm of adsorbed salivary components
prior to adhesion of bacteria or yeasts, experiments in the
human oral cavity have demonstrated that the properties
of this conditioning ﬁlm are determined by the material
itself.40,41 As a consequence, bioﬁlm formation can be
inﬂuenced by adjusting the properties of the voice prosthe-
ses material or by surface modiﬁcation.
A brief description of several methods used for silicone
rubber surface modiﬁcations is listed in Table II.
Metal Coating Techniques
Arweiler-Harbeck et al.42 aimed at creating a Candida-
resistant surface by either gold or titanium coating of
silicone voice prostheses using a new method of surface
modiﬁcation by anodic vacuum arc coating. Although no
functional change in the properties of the prostheses and no
difference in the quality of speech were reported by
patients as a result of metal coating, further studies are
needed to show that metal coating with gold or titanium
lead to a retardation of Candida growth.
Balazs et al.43 reported that silver impregnation of poly-
vinyl chloride completely inhibited P. aeruginosa adhesion
and efﬁciently prevented colonization over a longer period.
However, despite the high antimicrobial activity of silver
coatings, silver is toxic if ingested, which is an obvious
drawback as a voice prosthesis is nothing more than a tra-
cheoesophageal shunt. Furthermore, silver produces a
rough, high-energy surface, which can promote plaque for-
mation and maturation.55
Dijk et al.44 treated Groningen button voice prostheses
with a colloidal palladium/tin solution to form a thin metal
coat and showed signiﬁcant bioﬁlm reduction on the heav-
ily palladium/tin-treated prostheses in comparision to the
untreated prostheses. Therefore, palladium/tin-treated sili-
cone rubber may potentially extend the lifetime of indwell-
ing voice prostheses.
Plasma Surface Treatment Technique
Polymeric surfaces can be efﬁciently modiﬁed by a glow-
discharge plasma treatment, in which a nonpolymer form-
ing plasma (i.e. plasma of argon, oxygen or nitrogen) is
used. Plasma treatment essentially modiﬁes the composition
and structure of a few molecular layers at or near the sur-
face of the material without affecting the bulk properties.49
Everaert et al.45 investigated the effects of repeated ar-
gon plasma treatment of medical grade hydrophobic sili-
cone rubber on in vitro adhesion and growth of selected
bacteria and yeasts isolated from voice prostheses, as well
as in vivo bioﬁlm formation. The results obtained for
in vivo experiments showed a reduction in microbial adhe-
sion and growth on silicone rubber. However, in vivo bio-
ﬁlm formation on silicone rubber voice prostheses was
oppositely enhanced by hydrophilizing the silicone rubber
surface. Several reasons may explain such contradictory
results for in vitro and in vivo evaluation of the fouling
properties including the wide variability of strains occur-
ring in vivo, the different cell surface properties, and the
coadhesion phenomena between bacteria or yeasts in vivo,
which make in vitro evaluations difﬁcult. Finally, the con-
ditions in the oropharyngeal cavity (in vivo) are highly
dynamic with regard to nutrient availability, temperature,
humidity, and shear forces.
Perﬂuoro-Alkylsiloxane Surface Treatment
Everaert et al.45 demonstrated that bioﬁlm formation on
voice prostheses surfaces in vivo is governed by substratum
hydrophobicity. Therefore, the improved antifouling per-
formance of voice prostheses may be achieved through
increasing the hydrophobicity of the silicone rubber such as
by adsorption of ﬂuorocarbons (Teﬂon) to the surface. Flu-
orocarbon surfaces are slightly more hydrophobic than sili-
cone rubber and were reported to hardly attract any dental
plaque during nine days of exposure to the dynamic condi-
tions of the human oral cavity.56 Additionally, the same
authors46 prepared reactive surfaces by argon plasma glow
discharge prior to anchoring ﬂuoro-alkyltrichlorosilanes. A
promising aspect of chemisorbed long chain ﬂuoro-alkylsi-
loxanes to silicone rubber is that they were found to reduce
microbial adhesion and to increase the percentage of
detachment of adhering microorganisms. Finally, these
authors47 also reported signiﬁcant reductions over an evalu-
ation period of approximately two to eight weeks when
using chemisorption of long (8 ﬂuorocarbon units) per-
ﬂuoro-alkylsiloxane (PA) polymer chains due to the high
hydrophobicity and mobility of these chains.
Covalently Coupled Quaternary Ammonium
Silane Coatings
Another possible strategy to prevent voice prostheses micro-
bial colonization is by functionalization of the silicone rub-
ber surface with quaternary ammonium groups, widely
known as antimicrobial agents (disinfectants). Poly(metha-
crylates) with methyl or ethyl quaternary ammonium chlo-
ride side groups showed antimicrobial activity48,57,58 against
Gram-negative strains, although Gram-positive staphylococci
were little affected by these polymers.
Gottenbos et al.20 determined the antimicrobial activity of
3-(trimethoxysilyl)-propyldimethyloctadecylammonium chlo-
ride (QAS) coating on silicone rubber. Antimicrobial activity
of QAS-coated silicone rubber was demonstrated both
in vitro and in vivo. The application of positively charged
biomaterial surfaces to prevent infection is unusual as cur-
rent research has been mainly focused on designing nonad-
hesive surfaces. Positively charged surfaces are strongly
adhesive to the negatively charged bacteria; however, the
positive charge inhibited bioﬁlm progression from the initial
adhesion stage toward growth stage since immobilized QAS
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molecules interact with the cell membranes of adhering bac-
teria, presumably causing membrane leakage and cell death.
Bulk Surface Modiﬁcation Techniques
Bulk surface modiﬁcation methods can be achieved through
blending, copolymerization, interpenetrating polymer net-
works, and functionalization. Among these mentioned bulk
modiﬁcation techniques, laser-induced surface grafting and
sequential method for interpenetrating polymer network
preparation have the potential for local modiﬁcation of a
speciﬁc section on a polymeric sample.
A simple procedure for synthesizing dense and homoge-
neous poly(methyl methacrylate) brushes on silicon sub-
strates is by atom-transfer radical polymerization process
starting from self-assemble monolayers of covalently anch-
ored initiators as described by Ramakrishnan et al.50 An
advantage of the system described in comparison to similar
systems on gold surfaces is that the polymers are anchored
very strongly to the SiO2 surfaces and survive even drastic
extraction conditions without loss of chains, thus enabling
its use in biomedical applications.
The Use of Surface Active Molecules (Biosurfactants)
Biosurfactants are microbial amphiphilic and polyphilic
polymers that tend to interact with the phase boundary
between two phases in a heterogeneous system, deﬁned as
interface, interfering with the microbial adhesion and
detachment process. Biosurfactants may be oriented in dif-
ferent ways at the microbial cell surface. However, regard-
less of their orientation, if they are released from the cell
surface or excreted into the area between the cell surface
and interface, they will probably lead to detachment of bac-
teria from the interface.
Biosurfactants have become an important biotechnologi-
cal product for industrial and medical applications.59,60 Their
popularity as high value microbial products is related to their
speciﬁc action, low toxicity, relative ease of preparation, and
widespread applicability.61 They can be used as emulsiﬁers,
de-emulsiﬁers, wetting agents, spreading agents, foaming
agents, functional food ingredients, and detergents in various
industrial sectors.62 Several studies concerning the applica-
tions, production methods, and characterization of biosurfac-
tants are described in the literature.63,64
The role of biosurfactants as defense weapons in postad-
hesion competition with other strains or species has been
suggested for biosurfactants released by Streptococcus mitis
strains against Streptococcus mutans adhesion.65–67 Studies
have also shown that certain strains of bacteria, such as Lac-
tobacillus strains, commonly found in healthy urogenital
microﬂora, can protect the host against infection by inhibi-
ting uropathogens68–70 and biosurfactant production is one of
the mechanisms by which they are speculated to achieve
this.67,71 Velraeds et al.67,72 determined the role of these bio-
surfactants as anti-adhesive, nonantibiotic coatings on cathe-
ter surfaces. However, only one pathogen (E. faecalis) was
studied and various degrees of inhibition were observed with
the various Lactobacillus strains. Therefore, it should not be
expected that biosurfactants of different Lactobacillus strains
will produce equivalent results for any given pathogen.
Another well-known group of biosurfactant producers
are S. thermophilus strains isolated from heat exchanger
plates in the dairy industry.73 Busscher et al.51 examined
whether biosurfactant release by S. thermophilus might pro-
long the lifetime of indwelling silicone rubber voice pros-
theses. To this end, the adhesion of different yeast strains,
isolated from Groningen button voice prostheses, to sili-
cone rubber in the presence and absence of biosurfactant-
releasing S. thermophilus B cells was studied. The results
obtained provide evidence in support of the belief among
laryngectomized patients and some ear–nose–throat clini-
cians that dairy products containing active bacteria may
prolong the lifetime of indwelling silicone rubber voice
prostheses. A later study extended into microbial growth
phase also indicated a positive effect of the biosurfactant
released by streptococci on bioﬁlm formation.52
Recently, we investigated the effect of biosurfactants
obtained from probiotic bacteria, L. lactis 53 and S. ther-
mophilus A, and also a rhamnolipid obtained from P. aeru-
ginosa DS10–129, on the adhesion of microbial strains
isolated from explanted voice prostheses to silicone rubber
with and without an adsorbed biosurfactant layer in a paral-
lel plate ﬂow chamber.53,74,75 The results obtained showed
that the biosurfactants obtained from probiotic bacteria
were more effective in decreasing both the initial de-
position rates and the number of microorganisms adhering
after 4 h for all microorganisms, as compared to the rham-
nolipid. The biosurfactant obtained from L. lactis 53 was
effective in decreasing the initial deposition rates of S. epi-
dermidis GB 9/6, Streptococcus salivarius GB 24/9, and
S. aureus GB 2/1, allowing for a 90% reduction of the dep-
osition rates (j0, Figure 1). The deposition rates of R. den-
tocariosa GBJ 52/2B, C. albicans GBJ 13/4A, and
C. tropicalis GB 9/9 were far less reduced than other
strains tested. Interestingly, the biosurfactant from S. thermo-
philus A was more effective in decreasing the initial depo-
sition rate of R. dentocariosa GBJ 52/2B, which is one of
the bacterial strains commonly associated with premature
voice prostheses failure. Both biosurfactants reduced the
numbers of microorganisms adhering to silicone rubber
after 4 h by approximately 90% (n4h, Figure 2), except for
C. albicans GBJ 13/4A, C. tropicalis GB 9/9 and R. dento-
cariosa GBJ 52/2B that showed less reductions ranging
between 56 and 70%. Further work was developed54 to
assess the inﬂuence of these biosurfactants in the bioﬁlm
formation on voice prostheses (Figure 3). Both biosurfac-
tants greatly reduced microbial numbers on prostheses and
also induced a reduction in the airﬂow resistance of voice
prostheses after bioﬁlm formation. The use of biosurfactants
obtained from probiotic bacteria may represent a promising
strategy to prevent microbial colonization of silicone rubber
voice prostheses, thus prolonging their lifetime.
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PROPHYLATIC TREATMENT ON SILICONE
RUBBER VOICE PROSTHESES
It is well-known that bioﬁlms are resistant to a range of anti-
fungal agents currently in clinical use, including amphotericin
B and ﬂuconazole, and there appear to be multiple resistance
mechanisms and thus alternative prophylactic treatments are
being explored to prolong voice prostheses lifetime.
The Use of Probiotics
As antimicrobial resistance is becoming a source of con-
cern in modern medicine and health-improving functional
foods are gaining in popularity, the development of alterna-
tive prophylactic and therapeutic agents, including probiot-
ics, has been investigated.76 Lactobacilli are one of the
most well-known probiotic bacterial genera and play an im-
portant role in the maintenance of a healthy intestinal and
Figure 1. The initial deposition rates (j0) of the bacterial strains (Staphylococcus epidermidis GB 9/6,
Streptococcus salivarius GB 24/9, Staphylococcus aureus GB 2/1, and Rothia dentocariosa GBJ 52/
2B) and yeast (Candida albicans GBJ 13/4A and Candida tropicalis GB 9/9) isolated from explanted
voice prostheses on silicone rubber with and without an adsorbed biosurfactant layer. Biosurfactant
1, 2, and 3 were obtained from L. lactis 53, S. thermophilus A, and P. aeruginosa DS10–129, respec-
tively. Results are averages of triplicate experiments varying within 10–15% (ANOVA) and the stand-
ard deviation represented by error bars. Adapted from Rodrigues et al.53,74,75
Figure 2. The number of microorganisms adhering after 4 h (n4h) on silicone rubber with and without
an adsorbed biosurfactant layer. Biosurfactant 1, 2, and 3 were obtained from L. lactis 53, S. thermo-
philus A, and P. aeruginosa DS10–129, respectively. The codiﬁcation of the microorganisms is pre-
sented in Figure 1. Results are averages of triplicate experiments varying within 10–15% (ANOVA)
and the standard deviation represented by error bars. Adapted from Rodrigues et al.53,74,75
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urogenital tract.71 Other bacterial genera known to have
probiotic effects are lactococci, enterococci, and strepto-
cocci. The mechanisms by which probiotic bacteria exert
their beneﬁcial effects are not yet entirely understood.
Competitive adhesion,77,78 activation of the immune sys-
tem,79 and nutrient competition76 have all been suggested
as such mechanisms. Some strains are able to release bio-
surfactants, while others are known to have antimycotic
effects, produce lactic acid, or hydrogen peroxide.
Wagner et al.80 demonstrated that probiotic bacteria
have biotherapeutic potential for prophylaxis and therapy
against candidiasis. Free et al.76 assessed the inﬂuence of
probiotic bacteria (L. lactis 53 and S. thermophilus B) on
bioﬁlm formation on both Groningen and Provox voice
prostheses in an artiﬁcial throat model. It was found that
the strains affect the bioﬁlm formation on both types of
voice prostheses and increased lifetimes can be expected
from carefully designed food supplements containing these
bacteria. Alternatives for bacteria administration were pro-
posed, such as freeze-dried in sachets or in a dairy product.
The Effects of Dairy Products
Several studies were carried out to assess the beneﬁcial
effect of different dairy products on the lifetime of voice
prostheses, as patient support groups for laryngectomy
patients have suggested that buttermilk consumption not only
prolongs the clinical usefulness of indwelling silicone rubber
voice prostheses but can also resolve early leakage of dys-
functioning valves.51,81–85 Busscher et al.81 simulated the
consumption of buttermilk in an artiﬁcial throat model and
found that it almost completely prevented bioﬁlm formation
during the experimental period. The mechanism by which
the consumption of buttermilk interferes with bioﬁlm forma-
tion can only be speculated. Buttermilk is a mildly acidic
dairy product with a pH of 4.5 due to the presence of lactic
acid produced by L. lactis and Streptococcus cremoris, and
contains a number of enzymes in addition to high calcium
content (110–120 mg per 100 g). L. lactis strains are known
to release antimycotic substances, while the proteins present
in buttermilk include casein, lactoglobulin, and immunoglo-
bulins, which may have detergent properties. Clearly, the
combined effect of all properties of buttermilk contributes to
the referred prevention of bioﬁlm formation. Moreover, Free
et al.85 demonstrated that it is feasible to formulate a dairy
product based on probiotics that will strongly inhibit bioﬁlm
formation on voice prostheses.
The Effects of Caffeinated Soft Drinks
The inﬂuence of caffeinated soft drinks on bioﬁlm forma-
tion on silicone rubber voice prostheses was also investi-
gated in an artiﬁcial throat model34 and a reduced bacterial
prevalence in the bioﬁlms to 1–5% of the control was
observed, while yeasts thrived in the bioﬁlms. Free et al.34
suggested caffeine or a combination of a low pH and high
sugar content as possible causes. The relevance of the
results achieved for laryngectomized patients has to be
established in a clinical trial, which might be difﬁcult
because of the multiple factors inﬂuencing bioﬁlm forma-
tion on voice prostheses in vivo.
The Use of Antifungal Agents
A strategy frequently applied by otolaryngologists to solve
the rapid colonization of voice prostheses is oropharyngeal
yeast decontamination by using antifungal agents, despite
the fact that there is no compelling evidence that prescrip-
tion of antifungal agents will prolong the lifetime of voice
prostheses. Moreover, the prophylactic use of antifungal
agents contributes to the development of resistant strains.
Many efforts have been made to develop new antifungal
drugs, as well as to clarify their effects on the lifetime of
voice prostheses.14,25,39,86–91 Oropharyngeal yeast decon-
tamination using amphotericin B lozenges and buccal adhe-
sive slow-release tablets containing miconazole nitrate has
been applied by otolaryngologists25,39 to increase the life-
time of voice prostheses. In studies25 with Groningen but-
ton voice prostheses, the successful decontamination of the
oropharynx with amphotericin B lozenges (10 mg) four
times daily was also associated with a prolonged device life
and lower airﬂow resistances. One of the drawbacks found
in using this agent is the need for daily applications, lead-
ing to poor compliance by the patients. Bodey87 reviewed
the available antifungal drugs and described new imida-
zoles, such as itraconazole and ﬂuconazole. Also, liposomal
preparations of amphotericin B were described as substan-
tially less toxic and more effective, clinical trials however
have yet to be carried out. Weissenbruch et al.39 conducted
a double-blind randomized trial among 36 laryngectomees
Figure 3. The percentage of viable bacteria and yeasts isolated
from the voice prostheses, with and without adsorbed biosurfac-
tants, after bioﬁlm formation in the artiﬁcial throat. Both for bacteria
and yeasts, the number of organisms found after using PBS as a
control was set at 100%. Also included are the decreases in airﬂow
resistance caused by bioﬁlms inﬂuenced by biosurfactants, com-
pared with the effects of PBS as a control. Biosurfactant 1 was
obtained from L. lactis 53 and biosurfactant 2 from S. thermophilus
A. All experiments were carried out in triplicate with separately cul-
tured strains. Adapted from Rodrigues et al.54
366 RODRIGUES ET AL.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
DOI 10.1002/jbmb
to assess the inﬂuence of a buccal bioadhesive slow-release
tablet (10 mg) containing miconazole nitrate on the lifetime
of the Provox voice prosthesis. All patients colonized with
Candida strains and treated with miconazole showed a sig-
niﬁcant decrease of colonization at the end of the study.
The airﬂow resistances were remarkably higher after two
months of follow-up in the placebo group. No local or
systemic adverse reactions to miconazole were observed
during this study. Patient compliance was acceptable ac-
cording to regular miconazole determination in saliva sam-
ples. The prostheses lifetime was signiﬁcantly higher in
patients treated with miconazole even after one year of fol-
low-up. The use of a buccal bioadhesive slow-release tablet
containing an antimycotic agent proves to be an adequate
method of preventing fungal colonization and deterioration
of silicone voice prostheses.
The Use of Synthetic Salivary Peptides
Salivary dysfunction as a result of surgical therapy, radiation
therapy, aging, or medication is frequently a problem for
many laryngectomees. The low salivary secretion reduces the
amount of histatins in saliva, yielding better chances for
opportunistic microorganisms such as C. albicans, as histatins
contains fungicidal activity.92 Artiﬁcial salivary substitutes,
commonly used by xerostomic patients and sometimes by
laryngectomy patients, now mainly contain carboxymethyl-
cellulose, animal mucins, or xanthan, and such substances
constitute an excellent vehicle for antifungal agents.93 Syn-
thetic salivary peptides are promising antimicrobial agents,
which can possess bactericidal and fungicidal activities.94
These salivary peptides have not so far been associated with
the development of microbial resistance. Helmerhorst et al.94
reported a number of basic antifungal peptides, including
human salivary histatin 5, a designed histatin analog desig-
nated dhvar4, and a peptide from frog skin, PGLa, that are
active against amphotericin B-resistant C. albicans, C. krusei,
and Aspergillus fumigatus strains and against a ﬂuconazole-
resistant C. glabrata. In addition, Elving et al.95 studied the
antimicrobial activity of different synthetic salivary peptides
derived from histatin against a variety of oropharyngeal
microorganisms isolated from explanted voice prostheses.
Designed histatin analogs designated dhvar4 and dhvar5 were
the only synthetic peptides with an antimicrobial spectrum
broad enough to cover the variety of oropharyngeal micro-
organisms found on voice prostheses.
Recently, Oosterhof et al.96 carried out experiments in
an artiﬁcial throat to determine the effectiveness of dhvar4
and dhvar5 on oropharyngeal bioﬁlm formation. The
dhvar4 had no effect on mixed bioﬁlms, while dhvar5 sig-
niﬁcanly reduced the number of both bacteria and yeasts in
mixed bioﬁlms. However, this reduction was not accompa-
nied by a reduction in airﬂow resistance, suggesting that
the integrity of the bioﬁlm was not affected. This may be
due to the remaining exopolysaccharide (EPS) and connect-
ing slime threads within the bioﬁlm, as the integrity of a
bioﬁlm is determined by the EPS matrix rather than by the
number of organisms within. This was conﬁrmed by the
observation that both ascorbic acid and N-acetylcysteine
induced similar reduction in the number of bacteria and
yeasts, probably due to their antioxidant natures. Treatment
with ascorbic acid did not result in a decrease in airﬂow re-
sistance, whereas treatment with the mucolytic N-acetylcys-
teine did. Perez-Giraldo et al.97 studied the inﬂuence of
various concentrations of N-acetylcysteine on the formation
of bioﬁlms of different strains of S. epidermidis and found
a dose-related decrease in bioﬁlm and slime formation. N-
acetylcysteine, therefore, is a promising chemical to disrupt
the integrity of voice prostheses bioﬁlms, especially since it
can be swallowed and used over a long period without
adverse effects.
CONCLUDING REMARKS
The insertion of silicone rubber voice prostheses in a tra-
cheoesophageal shunt is generally considered to be the
main procedure for speech rehabilitation of laryngectom-
ized patients. These implants need to be replaced when
leakage through or around the prosthesis occurs, or when it
becomes difﬁcult to produce tracheoesophageal speech due
to increased airﬂow resistance. A continuous exposure to
saliva, food, drinks, and oropharyngeal microﬂora contrib-
ute to rapid colonization of the prostheses by bioﬁlms of
mixed bacteria and yeasts strains leading to failure and fre-
quent replacement. Achieving an antifouling improvement
for the silicone rubber material by the development of new
biomaterials or new antimicrobial agents is highly desira-
ble. This review describes the different approaches avail-
able to date and discusses future perspectives on solving
the voice prostheses drawbacks. When designing new bio-
materials, inhibition of microbial adhesion and growth
should be achieved by changing the physicochemical prop-
erties of the biomaterial surface or by covalently binding
antimicrobial agents to the biomaterial surface. Techniques
used to modify silicone rubber surfaces and prophylactic
treatments for silicone rubber voice prostheses have shown
varying effects in the inhibition of bioﬁlm formation and
therefore in the lifetime of these prostheses. As antimicro-
bial resistance is a growing source of concern in modern
medicine, the development of novel alternative prophylactic
and therapeutic agents, including probiotics and other sur-
face active compounds such as biosurfactants are expected
to gain prominence in the future antifouling strategies.
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